Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antag

Details Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antag Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antag

1993-07-21

1994-10-18

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

5142342, 5142345, 514246, 544113, 544209, 544212, A61K 31535, C07D41306

Patent

active

053568940

ABSTRACT:
##STR1## The invention concerns novel, pharmaceutically useful compounds of formula I in which Q is a 5-membered heteroaryl optionally bearing 1 or 2 substituents independently selected from (1-4C)alkyl and halogeno;

REFERENCES:
patent: 3995039 (1976-11-01), Rooney et al.
patent: 4133674 (1979-01-01), Cartwright
Ried et al., Tetrahedron, 44(23), 7155-62, 1988.
Ried, W. et al., "Synthesis of New Substituted Pyrazolo [1,5-a]-Pyrimidines and Pyrazolo [1,5-a]1,3,5-riazines", Tetrahedron vol. 44, No. 23, 1988, pp. 7155 to 7162.
Akerblom et al., "Nitrofuryltriazole Derivatives as Potential Urinary Tract Antibacterial Agents", J. Med. Chem. vol. 16, No. 4, pp. 312-319, 1973.

Affiliated with

Also associated with

Rating

Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antag does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antag will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2372599